Completed PHASE4 INTERVENTIONAL NCT00170261

ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope

Early Loop-Recorder in Suspected Arrhythmogenic Syncope

Sponsor: Medtronic

Conditions Syncope

Interventions Use of an Implantable Loop Recorder

Updated 7 times since 2017 Last updated: Jun 30, 2025 Started: Apr 30, 2002 Primary completion: Sep 30, 2005 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00170261, this PHASE4 trial focuses on Syncope and remains completed. Sponsored by Medtronic, it has been updated 7 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Completed PHASE4
Jul 2025 — Aug 2025 [monthly]

Completed PHASE4
Sep 2024 — Jul 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany
• Hamburg, Germany